A Study to Evaluate the Effects of a Prebiotic and Probiotic Supplement to Provide Relief From Symptoms Associated With Bacterial Vaginosis and Yeast Infections.
Part of paid clinical trials in Santa Monica, California.
- Sponsor
- Happy V
- Study ID
- NCT06665126
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Bacterial Vaginosis
- Yeast Infection
Eligibility Criteria
- Sex
- FEMALE
- Age
- 25 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Prebiotic + Probiotic Supplement — DIETARY_SUPPLEMENTThis intervention includes a combination of prebiotics and probiotics designed to promote vaginal and digestive health. The supplement contains Biotin, Lactobacillus acidophilus (as LA-14®), Bifidobacterium lactis (HN019™), Lactobacillus rhamnosus (as HN001™), Lactobacillus crispatus (as CCFM1110™), Lactobacillus gasseri (as HLG13™), Lactobacillus reuteri (as HR7™), Bacillus subtilis (as DE111®), PreforPro®, White Rice Flour, Magnesium Stearate (Vegetable Source), Silicon Dioxide (Bamboo Source), and Cellulose (Vegetable Capsule). Participants take two capsules daily with food for 30 days.
- Active Placebo Supplement — DIETARY_SUPPLEMENTThe active placebo supplement contains similar probiotic strains without the prebiotic component. Ingredients include Biotin, Lactobacillus acidophilus, Bifidobacterium lactis, Lactobacillus rhamnosus, Lactobacillus crispatus, Lactobacillus gasseri, Lactobacillus reuteri, Bacillus subtilis, Inulin (from Chicory Root), White Rice Flour, Magnesium Stearate (Vegetable Source), Silicon Dioxide (Bamboo Source), and Cellulose (Vegetable Capsule). Participants take two capsules daily with food for 30 days.
- Excipient Placebo Supplement — DIETARY_SUPPLEMENTThe excipient placebo supplement contains no active ingredients related to prebiotics or probiotics. It includes White Rice Flour, Magnesium Stearate (Vegetable Source), and Cellulose (Vegetable Capsule). Participants take two capsules daily with food for 30 days.
Study Details
This virtual randomized controlled trial evaluates the efficacy of a prebiotic and probiotic supplement in providing relief from symptoms associated with bacterial vaginosis and yeast infections. Participants will be randomized into three groups-test product, active placebo, and excipient placebo-and will take two capsules daily for 30 days. The study will assess the effects on vaginal microbiome, symptoms of bacterial vaginosis and yeast infections, and overall vaginal health.
Key Dates
- Start date
- Nov 1, 2024
- Status verified
- Oct 2024
- Primary completion
- May 1, 2025
- Completion
- May 30, 2025
Study Design
- Enrollment
- 120 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Test Product GroupParticipants in this group will receive the test product, a prebiotic and probiotic supplement.
- Placebo Comparator: Active Placebo GroupParticipants in this group will receive an active placebo.
- Placebo Comparator: Excipient Placebo GroupParticipants in this group will receive an excipient placebo.
Primary Outcome Measure
Change in Vaginal Microbiome [ Time Frame: Baseline, Day 30 ]
Central Contacts
- Patrick Renner, MSc4242450284
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Citruslabs | Santa Monica | California | 90404 |
Find similar trials in Santa Monica, CA
Related Studies
- Vaginal Ecosystem and Network in the United States StudyEnrolling By Invitation · Vaginal Biome Science · Fullerton, California
- Clinical Protocol CERN Feasibility StudyRecruiting · Cern Corporation · Irvine, California
- Prospective Data Bank Creation to Study Vaginal ConditionsRecruiting · Texas Tech University Health Sciences Center · Midland, Texas
- Exploring the Effects of an Intravaginal Lactic Acid Gel on the Vaginal MicrobiomeEARLY_PHASE1 · Recruiting · Queen's Medical Center · Honolulu, Hawaii